Nipro Company, Ltd.
Japan JP-MF-000026759 Last updated 22 Oct 2026 Part of Nipro Corporation
- Devices
- 163
- Registries
- EUDAMED
- FDA recalls
- 1
Catalogue
Dental Needle Ref 7710
Curacase Ref ZT002-009-0001-020
Curacase Ref ZT002-009-0001-006
Curacase Ref ZT002-009-0001-016
Curacase Ref ZT002-009-0001-003
Curacase Ref ZT002-009-0001-030
Dental Needle Ref 7716
Curacase Ref ZT002-009-0001-014
Surdial X Ref Type C 230V
Curacase Ref ZT002-009-0001-005
Surdial X Ref Type D 230V
Curacase Ref ZT002-009-0001-001
Curacase Ref ZT002-009-0001-021
Dental Needle Ref 7711-100
Curacase Ref ZT002-009-0001-009
Curacase Ref ZT002-009-0001-013
Curacase Ref ZT002-009-0001-022
Curacase Ref ZT002-009-0001-011
Dental Needle Ref 7717-100
Surdial X Ref Type A 230V
Dental Needle Ref 7713
Curacase Ref ZT002-009-0001-023
Surdial X Ref Type B 230V
Curacase Ref ZT002-009-0001-017
Dental Needle Ref 7711
Dental Needle Ref 7717
Curacase Ref ZT002-009-0001-018
SURDIAL 55Plus Ref SURDIAL 55Plus
Curacase Ref ZT002-009-0001-028
Curacase Ref ZT002-009-0001-008
Curacase Ref ZT002-009-0001-025
Curacase Ref ZT002-009-0001-012
Elisio Ref ELI-15H-GC
Elisio Ref ELI-19L-GJ
Pressone Ref ZT002-009-0001-007
Elisio Ref ELI-21M-PO-GJ
Curacase Ref ZT002-009-0001-027
Curacase Ref ZT002-009-0001-024
Curacase Ref ZT002-009-0001-004
Elisio Ref ELI-09HX-GJ
Curacase Ref ZT002-009-0001-002
Elisio Ref ELI-17H-PO-GJ
Curacase Ref ZT002-009-0001-010
Curacase Ref ZT002-009-0001-026
Curacase Ref ZT002-009-0001-029
Elisio Ref ELI-25HX-GJ
Fb Ref FB 13U-GJ
Curacase Ref ZT002-009-0001-019
Elisio Ref ELI-19H-GC
Sureflux Ref SF-05L-GJ
Showing 1-50 of 163
FDA recalls
Nipro Company, Ltd. has one FDA recall record initiated on 2002-11-08, which is marked as terminated. The recall was due to the potential for air or fluid leakage at the hub/needle junction.
2002
- 8 Nov 2002 Z-0408-03 Unclassified (pre-2012) Terminated Air or fluid leakage at the hub/needle junction.
What Nipro Company, Ltd. makes
Nipro Company, Ltd. manufactures bedside medical consoles, including the HA-57P model, and intravenous infusion pumps such as the BIP-BH blood and heparin pump. These devices are designed for hospital use to administer fluids and medications while providing integrated monitoring and control functions at the patient’s bedside.
The company’s products fall under FDA Class II regulatory classification and are listed via the 510(k) clearance pathway. These devices are intended for use in the United States, where they must comply with applicable FDA requirements for safety and performance.
Frequently asked questions
What types of medical devices does Nipro Company, Ltd. manufacture?
Nipro Company, Ltd. specializes in bedside medical consoles and intravenous infusion pumps. For example, they produce the HA-57P bedside console, which integrates monitoring and control functions, as well as the BIP-BH blood and heparin pump. These devices are designed for hospital environments to administer fluids and medications safely at the patient’s bedside.
Where is Nipro Company, Ltd. based, and where are their devices primarily used?
Nipro Company, Ltd. is based in the United States. Their devices, including infusion pumps and bedside consoles, are intended for use in U.S. healthcare settings, where they must meet FDA regulatory requirements for safety and performance.
How are Nipro Company, Ltd.’s devices classified by the FDA, and what pathway is used for their authorization?
Nipro Company, Ltd.’s devices, such as the HA-57P bedside console and BIP-BH blood pump, fall under FDA Class II regulatory classification. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness. The company’s devices are authorized through the FDA’s 510(k) clearance pathway, which demonstrates substantial equivalence to a legally marketed predicate device.
Which regulatory registries or databases list Nipro Company, Ltd.’s medical devices?
Nipro Company, Ltd.’s devices are listed in the FDA’s 510(k) clearance database. This registry confirms that their products, including infusion pumps and bedside consoles, have undergone the required review process to demonstrate compliance with FDA regulations for Class II devices.
Information
- Country
- Japan
- Address
- 3-26, Senriokashinmachi, Settsu, Osaka, Japan
- Website
- nipro.co.jp
- [email protected]
- PRRC contact
- Toyoshi YOSHIDA
- EUDAMED SRN
- JP-MF-000026759